التفاصيل البيبلوغرافية
| العنوان: |
Use of thyroid supplements in relation to the risk of breast cancer. |
| المؤلفون: |
Shapiro S, Slone D, Kaufman DW, Rosenberg L, Miettinen OS, Stolley PD, Knapp RC, Leavitt T Jr, Watring WG, Rosenshein NB, Schottenfeld D |
| المصدر: |
JAMA [JAMA] 1980 Oct 10; Vol. 244 (15), pp. 1685-7. |
| نوع المنشور: |
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
| اللغة: |
English |
| بيانات الدورية: |
Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Print ISSN: 0098-7484 (Print) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE |
| أسماء مطبوعة: |
Original Publication: Chicago : American Medical Association, 1960- |
| مواضيع طبية MeSH: |
Breast Neoplasms/*chemically induced , Thyroxine/*adverse effects, Adult ; Aged ; Breast Neoplasms/diagnosis ; Female ; Humans ; Middle Aged ; Risk ; Thyroxine/administration & dosage |
| مستخلص: |
We conducted a case-control study to determine whether the use of thyroid supplements increases the risk of breast cancer. We compared 659 women with breast cancer and 1,719 control subjects. The rates of use of thyroid supplements were 9.1% and 8.7%, respectively (age-standardized rate ratio, 1.0; 95% confidence interval, 0.7 to 1.3). There was no evidence of an association when women known to be at increased risk for breast cancer (eg, nulliparae) were examined, even when thyroid supplements were taken for more than 15 years. Overall, there were no grounds to suggest that the long-term use of thyroid supplements increases the risk of breast cancer. |
| معلومات مُعتمدة: |
N01-CB-74099 United States CB NCI NIH HHS; N01-CP-71029 United States CP NCI NIH HHS; N01-HD-6-2829 United States HD NICHD NIH HHS |
| المشرفين على المادة: |
Q51BO43MG4 (Thyroxine) |
| تواريخ الأحداث: |
Date Created: 19801010 Date Completed: 19801125 Latest Revision: 20161017 |
| رمز التحديث: |
20221213 |
| PMID: |
7411825 |
| قاعدة البيانات: |
MEDLINE |
